154 related articles for article (PubMed ID: 10489988)
1. Production of sleeping-sickness treatment.
Pécoul B; Gastellu M
Lancet; 1999 Sep; 354(9182):955-6. PubMed ID: 10489988
[No Abstract] [Full Text] [Related]
2. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
[TBL] [Abstract][Full Text] [Related]
3. Melarsoprol-free drug combinations for second-stage Gambian sleeping sickness: the way to go.
Chappuis F
Clin Infect Dis; 2007 Dec; 45(11):1443-5. PubMed ID: 17990226
[No Abstract] [Full Text] [Related]
4. Cost-effectiveness analysis of alternative treatments of African gambiense trypanosomiasis in Uganda.
Politi C; Carrín G; Evans D; Kuzoe FA; Cattand PD
Health Econ; 1995; 4(4):273-87. PubMed ID: 8528430
[TBL] [Abstract][Full Text] [Related]
5. The treatment of human African trypanosomiasis.
Pépin J; Milord F
Adv Parasitol; 1994; 33():1-47. PubMed ID: 8122565
[No Abstract] [Full Text] [Related]
6. [The return of sleeping sickness in an epidemic form: international action for drugs].
Kager PA
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2527-30. PubMed ID: 12532663
[TBL] [Abstract][Full Text] [Related]
7. Advances in sleeping sickness therapy.
Van Nieuwenhove S
Ann Soc Belg Med Trop; 1992; 72 Suppl 1():39-51. PubMed ID: 1417168
[TBL] [Abstract][Full Text] [Related]
8. [Agents for the treatment of African sleeping sickness. Those developed in the last century].
Schlitzer M
Pharm Unserer Zeit; 2009; 38(6):552-8. PubMed ID: 19862727
[No Abstract] [Full Text] [Related]
9. Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola.
Robays J; Raguenaud ME; Josenando T; Boelaert M
Trop Med Int Health; 2008 Feb; 13(2):265-71. PubMed ID: 18304274
[TBL] [Abstract][Full Text] [Related]
10. The rise and fall of sleeping sickness.
Barrett MP
Lancet; 2006 Apr; 367(9520):1377-8. PubMed ID: 16650633
[No Abstract] [Full Text] [Related]
11. Gambian trypanosomiasis and synergism between melarsoprol and eflornithine: first case report.
Simarro PP; Asumu PN
Trans R Soc Trop Med Hyg; 1996; 90(3):315. PubMed ID: 8758090
[No Abstract] [Full Text] [Related]
12. Anti-sleeping sickness drugs and cancer chemotherapy.
Barrett SV; Barrett MP
Parasitol Today; 2000 Jan; 16(1):7-9. PubMed ID: 10637579
[No Abstract] [Full Text] [Related]
13. [Arsenical resistance and difluoromethylornithine in the treatment of human African trypanosomiasis].
Kazyumba GL; Ruppol JF; Tshefu AK; Nkanga N
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):591-4. PubMed ID: 3143492
[TBL] [Abstract][Full Text] [Related]
14. Availability and affordability of treatment for Human African Trypanosomiasis.
Etchegorry MG; Helenport JP; Pecoul B; Jannin J; Legros D
Trop Med Int Health; 2001 Nov; 6(11):957-9. PubMed ID: 11703853
[TBL] [Abstract][Full Text] [Related]
15. [Correspondence of the World Health Organization relative to the editorial by T. Ancelle (Med. Trop. 1996; 56: 347-348)].
Cattand P; Jannin J
Med Trop (Mars); 1997; 57(1):102-4. PubMed ID: 9289598
[No Abstract] [Full Text] [Related]
16. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.
Balasegaram M; Young H; Chappuis F; Priotto G; Raguenaud ME; Checchi F
Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):280-90. PubMed ID: 18947846
[TBL] [Abstract][Full Text] [Related]
17. Current chemotherapy of human African trypanosomiasis.
Docampo R; Moreno SN
Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
[TBL] [Abstract][Full Text] [Related]
18. Treatment of human African trypanosomiasis--present situation and needs for research and development.
Legros D; Ollivier G; Gastellu-Etchegorry M; Paquet C; Burri C; Jannin J; Büscher P
Lancet Infect Dis; 2002 Jul; 2(7):437-40. PubMed ID: 12127356
[TBL] [Abstract][Full Text] [Related]
19. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda.
Matovu E; Enyaru JC; Legros D; Schmid C; Seebeck T; Kaminsky R
Trop Med Int Health; 2001 May; 6(5):407-11. PubMed ID: 11348535
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda].
Legros D; Fournier C; Gastellu Etchegorry M; Maiso F; Szumilin E
Bull Soc Pathol Exot; 1999 Jul; 92(3):171-2. PubMed ID: 10472443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
